|
The account reported finding chloraprep preactivated.A sample pack was received; the breather pouch was already torn open, orange staining was observed on the wrapped bag, near the two tear here labels, and on the applicator, and the activator clamp had been compressed.Finished good production records were reviewed and there were no line down situations, deviations, run-withouts, or non-conformance reports that might have had an impact on this issue; finished good pack build was reviewed and placement of the chloraprep component was found to be ideal.Based on the complaint details, medline confirmed that the chloraprep had preactivated; however, it is unknown what could have caused the preactivation to occur, and the quality team will monitor this issue for trending purposes.There were no reports of death, serious injury, medical intervention, or follow up care.It has been determined that the reported event could cause or contribute to serious injury if it were to occur again.In an abundance of caution, this is a reportable event.If additional information becomes available this report will be reopened and reevaluated.This medical device report (mdr) is being submitted as part of retrospective review activities, which include review of historical data in accordance with regulations at 21 cfr part 803.The information included in this mdr reflects the information reasonably known to the manufacturer at the time of this retrospective review and submission.
|